Baillie Gifford & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-214	Closed	-$7.96K	–	452
2023 Q1	$7.96K	Hold	214	–	–	﹤0.01%	406
2022 Q4	$9.7K	Hold	214	–	–	﹤0.01%	413
2022 Q3	$15K	Buy	214 +18	+9%	+$1.26K	﹤0.01%	370
2022 Q2	$13K	Buy	+196	New	+$13K	﹤0.01%	391